Context-dependent behavioral effects of interleukin-1 in the rhesus monkey (Macaca mulatta)

被引:23
作者
Friedman, EM
Reyes, TM
Coe, CL
机构
[1] UNIV CALIF SAN DIEGO, DEPT PSYCHIAT, SAN DIEGO, CA 92103 USA
[2] UNIV WISCONSIN, DEPT PSYCHOL, MADISON, WI 53706 USA
关键词
interleukin-1; sickness behavior; rhesus monkey; sleep; anxiety; cytokines; IMMUNE-SYSTEM; SICKNESS BEHAVIOR; NERVOUS-SYSTEM; SLEEP; CYTOKINES; INFECTION; MICE; RAT; LIPOPOLYSACCHARIDE; RESPONSES;
D O I
10.1016/0306-4530(96)00010-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The behavioral effects of recombinant human interleukin-1 alpha (IL-1) in rhesus monkeys (Macaca mulatta) were assessed in 3 experimental paradigms: (1) a testing situation in which an initial quiescent period was followed by a challenge designed to evoke agitation; (2) a novel environment with a social partner; and (3) a working memory-dependent nonspatial cognitive task. In the first two experiments we replicated our previous observations that a high IL-1 dose (25 mu g) induces somnolence in a quiet setting within 1 h. A lower IL-1 dose (1 ng) did not have these sedative properties, but both IL-1 doses significantly reduced the number of vocalizations made by the monkeys. In contrast, when the monkeys were challenged through direct eye contact with a human experimenter, the 25 mu g IL-1 dose significantly increased agonistic behavior. Finally, performance on a working memory-dependent task (delayed non-matching-to-sample) was unaffected by doses of IL-1 ranging from 1 to 25 mu g, possibly because the monkeys were tested after learning the task rather than during the acquisition phase. These results demonstrate that high levels of IL-1 in peripheral circulation can have potent behavioral effects in the nonhuman primate, but that the nature of the influence will depend on the context in which the animal is evaluated. Manifestation of cytokine-induced 'sickness behavior' appears to require a permissive environment. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:455 / 468
页数:14
相关论文
共 48 条
  • [1] NEUROPSYCHIATRIC MANIFESTATIONS OF HUMAN-LEUKOCYTE INTERFERON THERAPY IN PATIENTS WITH CANCER
    ADAMS, F
    QUESADA, JR
    GUTTERMAN, JU
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (07): : 938 - 941
  • [2] ANDERSON TD, 1993, INT REV EXP PATHOL, V34, P9
  • [3] [Anonymous], 1991, PSYCHONEUROIMMUNOLOG, DOI DOI 10.1159/000452902
  • [4] PYROGENS SPECIFICALLY DISRUPT THE ACQUISITION OF A TASK INVOLVING COGNITIVE PROCESSING IN THE RAT
    AUBERT, A
    VEGA, C
    DANTZER, R
    GOODALL, G
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 1995, 9 (02) : 129 - 148
  • [5] AUBERT A, 1995, S CYT SEP 11 13 1995
  • [6] BERNSTEIN IS, 1985, INT J PRIMATOL, V6, P209
  • [7] BERNSTEIN IS, 1974, AM SCI, V62, P304
  • [8] IMMUNOREGULATORY FEEDBACK BETWEEN INTERLEUKIN-1 AND GLUCOCORTICOID HORMONES
    BESEDOVSKY, H
    DELREY, A
    SORKIN, E
    DINARELLO, CA
    [J]. SCIENCE, 1986, 233 (4764) : 652 - 654
  • [9] CYTOKINES AS MODULATORS OF THE HYPOTHALAMUS PITUITARY-ADRENAL AXIS
    BESEDOVSKY, HO
    DELREY, A
    KLUSMAN, I
    FURUKAWA, H
    ARDITI, GM
    KABIERSCH, A
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 40 (4-6) : 613 - 618
  • [10] BLALOCK JE, 1984, J IMMUNOL, V132, P1067